
Director of Microbiology @KeckMedicineUSC | CPEP Fellow @ChildrensLA | Molecular Medicine PhD @ClevelandClinic @CWRUSOM | Happiest on 2 Wheels | Opinions=Mine
Los Angeles, CA
Joined May 2022
- Tweets24
- Following187
- Followers176
- Likes58
What an incredible two years it has been at CHLA. I had a fantastic #CPEP experience thanks to a wonderful team of superstar medical microbiologists and mentors @DienBard @ccpathmd. Passing the senior fellow baton to @jackstatmicro now!
Curious about what life as a CPEP fellow is like? Read four unique perspectives from current fellows here: secure-web.cisco.com/1mBk5mU…
Lucas Osborn, PhD, D(ABMM) retweeted
Today we report a detailed map of interactions between the immune system and the gut microbiome. @MicrobiomeTcell led the charge w/ help from Aishan Zhao and Kat Atabakhsh. @Nature 1/40
nature.com/articles/s41586-0…
Lucas Osborn, PhD, D(ABMM) retweeted
👋 We're looking to recruit a postdoc to our team.
If you're interested and have expertise in bacterial molecular genetics, synthetic organic chemistry, or infectious disease biology, please reach out!
@CCLRI
jobs.clevelandclinic.org/job…
Lucas Osborn, PhD, D(ABMM) retweeted
Struggle to provide stewardship of Broad Range PCR? Wish there was an objective system to help communicate expected ROI and limit low yield/low impact testing? An intuitive scoring system is a step in that direction academic.oup.com/ajcp/advanc…
Lucas Osborn, PhD, D(ABMM) retweeted
“It’s so important to have fun, which is easy to do when you’re in science” - George Stark, PhD
At 90 years old, Dr. George Stark is not slowing down.
The former chair of @CCLRI is still pursuing medical breakthroughs like a new treatment for skin cancer.
Over his long career, he's published 300+ papers and trained 100+ students.
Read more: cle.clinic/44ybvTZ
Lucas Osborn, PhD, D(ABMM) retweeted
Commentary, in press: If You're Not Confused, You're Not Paying Attention: Ochrobactrum Is Not Brucella tinyurl.com/mvmhmyn6
@ASMicrobiology A thread...
Lucas Osborn, PhD, D(ABMM) retweeted
Today we report that removing a strain from a complex microbiome can ripple through the community in an unpredictable (& useful) way. @MinWang_18 was the mastermind, with help from Mark Brown, Stan Hazen & crew. @CellCellPress 1/25
cell.com/cell/fulltext/S0092…
I got goosebumps the first time I watched you present this work at a Leducq meeting years ago. The translational application was so tangible to someone like me who often struggles to understand the impact of many "high impact" papers. Thank you for this contribution and congrats!
Today we report that an engineered skin bacterium, swabbed gently on the head of a mouse, can unleash a potent immune response against a distant tumor. @yerinchen led the charge w/ help from @DjenetBousbaine, @VeinbachsA, @BelkaidLab. @ScienceMagazine 1/26
science.org/doi/10.1126/scie…
2
493
Lucas Osborn, PhD, D(ABMM) retweeted
🧫@urogoldjournal
Conclusions from analyzing 12,000+ paired urinalysis & urine cultures:
① 10K CFU/mL threshold is better than 100K CFU/mL for detecting a UTI.
② Negative UA exhibits high accuracy for predicting the absence of a UTI.
🧫@gwerneburg
authors.elsevier.com/c/1gqvi…
Lucas Osborn, PhD, D(ABMM) retweeted
Great occasion for my 1st tweet! Proud contributor to this @Nature perspective on the ongoing debate questioning a fetal #microbiome. With 46 experts in #microbiome #science and related disciplines, we assess the evidence. The answer, an unambiguous ‘No’ https://xitter.cf/t.co/AK9JOyQGvs
Lucas Osborn, PhD, D(ABMM) retweeted
Christopher Walsh: 1944-2023
A giant indeed: the impact of his work is staggering. But Chris was even more impressive as a mentor. He was immeasurably devoted to, & loved by, his trainees. Nothing made him happier than doling out his wisdom. Superhuman & human at the same time.
Lucas Osborn, PhD, D(ABMM) retweeted
Gut microbial flavonoid catabolite reverses fatty liver disease in mice news-medical.net/news/202211… #FattyLiver #Hepatic #Steatosis #Liver #LiverDisease #flavonoid #catabolite @PNASNews @ClevelandClinic
Lucas Osborn, PhD, D(ABMM) retweeted
Excited and proud to see @LJOsborn's paper from his @CCLRI PhD work in its final form!!! 🎉🎉🎉
Check out "A gut microbial metabolite of dietary polyphenols reverses obesity-driven hepatic steatosis"
A 🧵1/6
👇👇👇 pnas.org/doi/10.1073/pnas.22…
While MPXV cases have waned in the USA, the global implications of this virus shall not be diminished! Check out our latest review on the topic with wonderful collaborators from @LACUSCMedCenter @LACUSC_ID @IDwithNWD @DienBard
secure-web.cisco.com/1q35GF4…
Lucas Osborn, PhD, D(ABMM) retweeted
Finally out! We looked at over 2,000 genomes to see how well the SGTF did at calling variants across multiple #SARSCoV2 waves. Really good genomic signature to rule in first Alpha then Omicron (BA.1, BA.4 and BA.5). nature.com/articles/s41598-0… @mini_kamboj @evrnyc @MSKPathology – at Philadelphia, PA
Let me hear you say it in the back, "speciate" =/= "specificate". Similar words with very different meanings in the world of microbiology.
6
Lucas Osborn, PhD, D(ABMM) retweeted
My unsolicited advice for applicants on the grad school market:
Don't be afraid to be someone's first grad student. As a former 1st grad student, I can say there are a LOT of pros to it!
Lucas Osborn, PhD, D(ABMM) retweeted
Yesterday was a historic day in plant biotech: a purple tomato engineered with high antioxidants was approved by @USDA @BigPurpleTomato helps prevent cardiovascular disease and fight cancer in humans.
This approval under new regulation ushers in a new era for plant synbio!




















